Yew Bio-Pharm Group, Inc.

OTCPK:YEWB Stock Report

Market Cap: US$10.3k

Yew Bio-Pharm Group Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Yew Bio-Pharm Group's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Food Industry Growth16.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update30 Sep 2021

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Yew Bio-Pharm Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:YEWB Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 21290-10
30 Jun 21393-20
31 Mar 21344-10
31 Dec 2027110
30 Sep 2025010
30 Jun 2015000
31 Mar 20181-10
31 Dec 1928100
30 Sep 1930070
30 Jun 1944-190
31 Mar 1946-1100
31 Dec 1838-1100
30 Sep 1837-630
30 Jun 1835-530
31 Mar 1836320
31 Dec 1741320
30 Sep 17471010
30 Jun 17501010
31 Mar 1751110
31 Dec 1651210
30 Sep 1657510
30 Jun 1647520
31 Mar 1636520
31 Dec 1530520
30 Sep 1514420
30 Jun 1511420
31 Mar 158420
31 Dec 148410
30 Sep 148510
30 Jun 148410
31 Mar 148410
31 Dec 137410
30 Sep 137230
30 Jun 137230
31 Mar 137230
31 Dec 127230

Quality Earnings: Insufficient data to determine if YEWB has high quality earnings.

Growing Profit Margin: Insufficient data to determine if YEWB's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if YEWB's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare YEWB's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if YEWB's earnings growth over the past year exceeded the Food industry average.


Return on Equity

High ROE: YEWB has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.